AtendimentoFavoritos
Acessar conta
Carrinho0

Meu Carrinho

    Total

    Finalização da Compra
    Buscar
    Advanced breast cancer
    Cód:
    491_9786203607000

    Por: R$ 382,53ou X de

    Comprar
    RESUMET-DM1 is the first of an experimental new cancer drug known as an antibody-drug conjugate. It demonstrates an improvement in progression-free survival over standard therapy in HER2-positive metastatic breast cancer. It combines two existing cancer drugs in order to deliver both drugs specifically to cancer cells: Trastuzumab, a monoclonal antibody to target cells that overproduce the HER2 protein; and, T-DM1 is a chemotherapeutic substance.This is the first ever presentation of an anti-HER2 antibody-drug conjugate used as a primary treatment for patients with advanced breast cancer, said Professor Perez. We are encouraged by the results. The study explained that T-DM1 has very good anti-tumor activity as well as much lower toxicity when evaluated side-by-side to the older standard. T-DM1 has displayed promising activity in preclinical studies.
    Veja mais

    Calcule o valor do frete e prazo de entrega para a sua região

    Quem comprou também comprou

    Quem viu também comprou

    Quem viu também viu